ARMC
American Research & Management Company Portfolio holdings
AUM
$362M
This Quarter Return
+5%
1 Year Return
-8.06%
3 Year Return
+35.07%
5 Year Return
+60.97%
10 Year Return
–
AUM
$234M
AUM Growth
+$234M
(+2.3%)
Cap. Flow
-$3.64M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
32.08%
Holding
403
New
10
Increased
41
Reduced
107
Closed
16
Top Buys
| 1 |
PVTBP
PrivateBancorp, Inc. Capital Trust IV Trust Preferred
PVTBP
|
$948K |
| 2 |
Biogen
BIIB
|
$608K |
| 3 |
CELG
Celgene Corp
CELG
|
$476K |
| 4 |
McCormick & Company Non-Voting
MKC
|
$437K |
| 5 |
WFC.PRJ.CL
Wells Fargo & Company
WFC.PRJ.CL
|
$417K |
Top Sells
| 1 |
EMC
EMC CORPORATION
EMC
|
$1.42M |
| 2 |
SPDR ICE Preferred Securities ETF
PSK
|
$949K |
| 3 |
Jefferies Financial Group
JEF
|
$819K |
| 4 |
ETP
Energy Transfer Partners L.p.
ETP
|
$690K |
| 5 |
FPO
First Potomac Realty Trust
FPO
|
$618K |
Sector Composition
| 1 | Technology | 18.16% |
| 2 | Healthcare | 15.89% |
| 3 | Consumer Staples | 14.27% |
| 4 | Financials | 10.27% |
| 5 | Energy | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
John Wiley & Sons Class A
WLY
$2.11B
| $2.78M | 1.19% |
61,671
-4,472
| -7% | -$201K |
|
|
DD
27
DELISTED
Du Pont De Nemours E I
DD
| $2.63M | 1.12% |
39,518
+1,525
| +4% | +$102K |
|
28
Adobe
ADBE
$147B
| $2.56M | 1.09% |
27,232
-131
| -0.5% | -$12.3K |
|
29
Stryker
SYK
$147B
| $2.42M | 1.03% |
25,984
-1,418
| -5% | -$132K |
|
30
Merck
MRK
$210B
| $2.4M | 1.03% |
45,452
-2,052
| -4% | -$108K |
|
|
AWH
31
DELISTED
Allied World Assurance Co Hld Lt
AWH
| $2.35M | 1.01% |
63,300
+9,375
| +17% | +$349K |
|
32
TC Energy
TRP
$53.9B
| $2.14M | 0.91% |
65,561
-10,805
| -14% | -$352K |
|
|
SFE
33
DELISTED
Safeguard Scientifics, Inc.
SFE
| $2.12M | 0.9% |
145,916
+9,500
| +7% | +$138K |
|
34
Coca-Cola
KO
$293B
| $2.1M | 0.9% |
48,887
-100
| -0.2% | -$4.3K |
|
35
iShares Biotechnology ETF
IBB
$5.67B
| $2.05M | 0.87% |
6,050
+550
| +10% | +$186K |
|
36
Gentex
GNTX
$6.06B
| $1.96M | 0.84% |
122,575
| – | – |
|
37
SPDR S&P Biotech ETF
XBI
$5.26B
| $1.93M | 0.83% |
27,550
+2,510
| +10% | +$176K |
|
|
WFC.PRJ.CL
38
DELISTED
Wells Fargo & Company
WFC.PRJ.CL
| $1.85M | 0.79% |
65,750
+14,850
| +29% | +$417K |
|
39
Toronto Dominion Bank
TD
$128B
| $1.84M | 0.79% |
47,036
| – | – |
|
40
Teleflex
TFX
$5.52B
| $1.77M | 0.76% |
13,459
-20
| -0.1% | -$2.63K |
|
41
F5
FFIV
$17.6B
| $1.75M | 0.75% |
18,080
-865
| -5% | -$83.9K |
|
42
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$29.5B
| $1.72M | 0.74% |
15,120
-1,210
| -7% | -$138K |
|
43
Berkshire Hathaway Class B
BRK.B
$1.08T
| $1.68M | 0.72% |
12,695
-115
| -0.9% | -$15.2K |
|
|
44
SPDR ICE Preferred Securities ETF
PSK
$811M
| $1.58M | 0.67% |
35,325
-21,247
| -38% | -$949K |
|
|
USB.PRM
45
DELISTED
U.S. Bancorp Depositary Shares, each representing 1/1000th interest in a share of Series F Non-Cumul
USB.PRM
| $1.45M | 0.62% |
50,550
+13,000
| +35% | +$373K |
|
|
RDS.B
46
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.44M | 0.61% |
31,195
-700
| -2% | -$32.2K |
|
47
AT&T
T
$206B
| $1.38M | 0.59% |
40,013
| – | – |
|
48
Novo Nordisk
NVO
$252B
| $1.36M | 0.58% |
23,395
-200
| -0.8% | -$11.6K |
|
49
Fortune Brands Innovations
FBIN
$6.84B
| $1.31M | 0.56% |
23,674
| – | – |
|
|
50
Biogen
BIIB
$20.8B
| $1.3M | 0.56% |
4,245
+1,985
| +88% | +$608K |
|